Shilpa Pharma Lifesciences Limited jobs and careers

About Shilpa Pharma Lifesciences Limited

Shilpa Pharma Lifesciences Ltd. (100% EOU) Unit-II – Raichur, Karnataka (India) Trusted Partner in API, Intermediates, and CDMO Services & High-Potency Manufacturing Solutions About Us: Shilpa Pharma Lifesciences Ltd., a wholly owned subsidiary of Shilpa Medicare Limited, is a leading pharmaceutical manufacturing company specializing in APIs, Intermediates, Peptides, Polymers, Payloads, and Linker Molecules, with a strong focus on end-to-end CDMO services. With over 10 active NCE programs, we are at the forefront of innovation, serving both global pharmaceutical innovators and generic companies. Established in 2009 year, the company has rapidly grown into a world-class pharmaceutical manufacturer known for its technical excellence, regulatory compliance, and scalable capacity. Key Capabilities: • API & CDMO Excellence: Specialized in both Oncology and Non-Oncology Small Molecules manufacturing. • Production Infrastructure: o 10 advanced API production blocks o Total reactor capacity: • 525 KL (~180,000 liters) for highly potent/cytotoxic products (up to OEB-5) • 970,000 liters for non-potent/non-cytotoxic products • Monthly Output: o 30 tons per month of high-quality APIs and intermediates • State-of-the-Art R&D Center: Fully equipped for process development, scale-up, and tech transfer to support innovator and generic programs. • Comprehensive Regulatory Approvals: Accredited by leading global agencies including: USFDA | WHO-GMP | EU-GMP | PMDA | KFDA | TGA | ANVISA | COFEPRIS | Russian GMP | TPD (Canada) Facility Overview: • Company: Shilpa Pharma Lifesciences Ltd. (100% EOU) • Location: Industrial Growth Centre, Raichur – Developed by KIADB • Land Area: 34 Acres • Built-up Area: 4.34 lakh sq. ft. • Workforce: ~1550 full-time employees (FTE) Why Partner with Shilpa Pharma Lifesciences Ltd: • End-to-End CDMO Capabilities • Highly Potent API Expertise up to OEB-5 • Global Regulatory Compliance • Flexible Scale: From Development to Comm